ArticleBioactive materials2026
Zwitterionic multifunctional coatings with strong hydration for ureteral stents to inhibit infectious encrustation.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A bioinspired long-acting chlorhexidine-eluting super-hydrophilic coating on vascular catheters prevents thrombosis and biofouling.Bioactive materials · 2027Article
- Intraluminal micro-stenting improves urinary tract reconstruction in murine kidney transplant model.Laboratory animal research · 2026Article
- Slippery when wet: The effect of a novel zwitterionic coating on silicone ureteral stents.Urolithiasis · 2026Article
- Review
- Preclinical development of engineered biomaterial-based artificial bladder demonstrating core functions in a large-animal orthotopic model.Materials today. Bio · 2026Article
- From biofilms to fibrosis: recent advances in research on the pathological microenvironment linked to ureteral stents and their surface functionalization.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the complex urinary environment, an effective method is needed to combat ureteral stent encrustation. Herein, recognizing that the adsorption of mineral salts is the initial step in the encrustation process, we utilized the barrier effect of hydration layers to inhibit encrustation. Through molecular dynamics simulations, sulfobetaine methacrylate can form a hydration layer, which repels encrustation ions in a simulated urinary environment, preventing attachment. Then, we developed a multifunctional zwitterionic polymer coating on the polyurethane stent (PU/ATS) by employing UV-initiated free radical polymerization combined with a dip-coating technique. The hydration layer endows the coating with superhydrophilicity and excellent lubricity, effectively resisting 96.1 % and 83.5 % of encrustation in 30 days and 90 days of urine flow simulation and significantly reducing the bacteria adhesion. PU/ATS demonstrated improved anti-encrustation and anti-biofilm performance under infected conditions compared to the Bard® InLay Optima® stent. Moreover, in the rat bladder encrustation model, the PU/ATS reduced encrustation by 99.6 % (no infected) and by 86.7 % (infected) without organ damage. Therefore, the PU/ATS, by leveraging the hydration layer mechanism as an effective barrier, provides a practical and highly promising solution to combat encrustation and its associated urological complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.